TNF and inflammatory bowel disease: We became intrigued by this observation, especially after the recent COVID-19-advisory from the Crohn’s and Colitis Foundation of America (CCFA) to IBD patients to pause or stop anti-TNF-α therapy if exposed or infected with SARS-CoV-2 (18).